| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/04/2008 | CN101193898A Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3H)-one derivatives |
| 06/04/2008 | CN101193897A Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
| 06/04/2008 | CN101193892A Macrocyclic heterocyclic aspartyl protease inhibitors |
| 06/04/2008 | CN101193886A New tricyclic angiotensin II agonists |
| 06/04/2008 | CN101193881A New bicyclic angiotensin II agonists |
| 06/04/2008 | CN101193874A 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming PPAR ligands, methods for production and the use thereof in the form of drugs |
| 06/04/2008 | CN101193656A Novel triglyceride reducing agent |
| 06/04/2008 | CN101193632A Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 06/04/2008 | CN101193560A A combination of seal oil and cold-pressed virgin olive oil |
| 06/04/2008 | CN101190906A Method for preparing carthamin yellow carthamus B and application thereof |
| 06/04/2008 | CN101190307A Traditional Chinese medicine compound preparations for treating congestive heart failure |
| 06/04/2008 | CN101190305A Externally-applied soft ointment for treating hemorrhoid |
| 06/04/2008 | CN101190300A Medicine for curing cerebral infarction and preparation method |
| 06/04/2008 | CN101190298A Traditional Chinese medicine for treating cardiac disease |
| 06/04/2008 | CN101190289A Traditional Chinese medicine for treating combined hemorrhoid postoperative edema pain |
| 06/04/2008 | CN101190287A Traditional Chinese medicine for treating high blood pressure |
| 06/04/2008 | CN101190286A Blood pressure reducing health-care tea and its making method |
| 06/04/2008 | CN101190285A Health-care tea for preventing stroke and its making method |
| 06/04/2008 | CN101190281A Prune tree extract and preparation method and application thereof |
| 06/04/2008 | CN101190261A Transdermal drug administration preventing and controlling hypertension |
| 06/04/2008 | CN101190254A Medicinal composition containing kudzu root or its extract and mongolian snakegourd or its extract |
| 06/04/2008 | CN101190253A Medicinal composition containing mongolian snakegourd and notoginseng |
| 06/04/2008 | CN101190209A Low molecule heparin sustained-release controlled-release capsule preparations and preparation method thereof |
| 06/04/2008 | CN101190207A Nifedipine sustained release tablets preparation method |
| 06/04/2008 | CN101190189A Low molecule heparin mucous membrane adhesive tablet preparations and preparation method thereof |
| 06/04/2008 | CN101190187A Fructose diphosphate sodium particle and preparation method thereof |
| 06/04/2008 | CN101190183A Clonidine hydrochloride multi-vesicular liposome and preparation method thereof |
| 06/04/2008 | CN101190180A Metoprolol sustained release medicinal compositions and preparation method thereof |
| 06/04/2008 | CN101190007A Nutrition food containing bran |
| 06/04/2008 | CN101189999A Persimmon leaf health tea |
| 06/04/2008 | CN100392079C Protein C or activated protein C-like molecules |
| 06/04/2008 | CN100391964C Rehmannia root oligose and its extracting method |
| 06/04/2008 | CN100391953C Medicinal use and extraction of cis-ligusticum lactone |
| 06/04/2008 | CN100391946C Method for preparing amlodipine benzenesulfonate |
| 06/04/2008 | CN100391537C Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B |
| 06/04/2008 | CN100391534C Modulation of smooth muscle cell proliferation |
| 06/04/2008 | CN100391513C Medicinal preparation for treating cardio and cerebral vascular disease and its preparation method and quality control method |
| 06/04/2008 | CN100391502C Medicine for fumigating and washing anal disease |
| 06/04/2008 | CN100391501C Medicinal wine for stabilizing blood pressure |
| 06/04/2008 | CN100391492C Burdock microecological formulation |
| 06/04/2008 | CN100391491C Medicine composition for treating cardiovascular diseases and preparation method thereof |
| 06/04/2008 | CN100391489C Medicinal composition containing borneol |
| 06/04/2008 | CN100391486C Application of red sage root in preparing medicine for treating aspirin resistance blood vessel disease |
| 06/04/2008 | CN100391484C Medicine for treating cardio-cerebrovascular disease |
| 06/04/2008 | CN100391463C Cyclovirobuxine dripping pill and its preparation process |
| 06/04/2008 | CN100391462C Enhanced drug delivery in transdermal systems |
| 06/04/2008 | CN100391459C Doxazosin mesilate slow releasing preparation |
| 06/04/2008 | CN100391452C Red sage root preparation for injection and its preparation method |
| 06/04/2008 | CN100391447C Freeze dried powder injection of coenzyme Q10 and its preparation process |
| 06/04/2008 | CN100391443C Ginseng-monkshood slow-release coating skeleton piller for treating qi asthenia and yang depletion and preparing method thereof |
| 06/04/2008 | CN100391442C Ginseng-monkshood slow-release coating preparation film controlled piller for treating qi asthenia and yang depletion and preparing method thereof |
| 06/04/2008 | CN100391441C Matrine elaioplast drop ball and its preparation method |
| 06/04/2008 | CN100391440C Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base |
| 06/03/2008 | US7381733 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
| 06/03/2008 | US7381729 Gastrointestinal fluid solubility; adenosine-1 receptor agonist; hypertension, congestive heart failure, renal failure |
| 06/03/2008 | US7381726 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 06/03/2008 | US7381704 Methods for use of short bioactive peptides |
| 06/03/2008 | US7381702 Methods of treating diabetes mellitus |
| 06/03/2008 | US7381699 Reagents and methods for smooth muscle therapies |
| 06/03/2008 | US7381429 Hormone replacemnent therapy; menopause, osteoporosis, cardiovascular disorders; stroke; sexual disorders |
| 06/03/2008 | US7381424 Hydrostatic delivery system for controlled delivery of agent |
| 06/03/2008 | CA2467964C Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 06/03/2008 | CA2401711C Cyclic amide derivatives |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/03/2008 | CA2203237C Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 06/03/2008 | CA2122596C Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 05/29/2008 | WO2008063984A2 Allosteric modulators of the a1 adenosine receptor |
| 05/29/2008 | WO2008063865A2 Biphosphonate inhalant formulations and methods for using the same |
| 05/29/2008 | WO2008063795A1 Biological pacemaker compositions and systems incorporating interstitial cells of cajal |
| 05/29/2008 | WO2008063712A1 Use of a2a adenosine receptor agonists in the treatment of ischemia |
| 05/29/2008 | WO2008063157A2 A nanoparticle-based anticoagulant |
| 05/29/2008 | WO2008062905A2 Heteromonocyclic compound and use thereof |
| 05/29/2008 | WO2008062861A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 05/29/2008 | WO2008062830A1 Spiroquinone compound and pharmaceutical composition |
| 05/29/2008 | WO2008062814A1 Hydrogen-dissolved aqueous solution and method for prolonging the life duration of hydrogen dissolved in the aqueous solution |
| 05/29/2008 | WO2008062740A1 Nitrogenated fused ring compound and use thereof |
| 05/29/2008 | WO2008062232A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | WO2008062201A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | WO2008062066A1 Methods for improving bioavailability of a renin inhibitor |
| 05/29/2008 | WO2008062047A1 Process for preparing a crystalline form of candesartan cilexetil |
| 05/29/2008 | WO2008061966A2 New use of flibanserin |
| 05/29/2008 | WO2008061805A1 Pharmaceutical compositions for the treatment of capillary arteriopathy |
| 05/29/2008 | WO2008061671A2 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
| 05/29/2008 | WO2008061622A1 Crystalline forms of aliskiren hemifumarate |
| 05/29/2008 | WO2008061329A2 PHα1B TOXIN, CDNA OF PHα1 B TOXIN GENE, PHARMACEUTICAL COMPOSITIONS CONTAINING PHα1B TOXIN, PROCESSES FOR THEIR OBTENTION AND PRODUCT |
| 05/29/2008 | WO2008061306A1 Metal delivery agents and therapeutic uses of the same |
| 05/29/2008 | WO2008043081A3 Liquid chalcogenide compositions and methods of manufacturing and using the same |
| 05/29/2008 | WO2008040649A3 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 05/29/2008 | WO2008040360A3 Use of hypothermia inducing drugs to treat ischemia |
| 05/29/2008 | WO2008036540A3 Rho kinase inhibitors |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2007076053A8 Stable s-nitrosothiol formulations |
| 05/29/2008 | US20080125490 the use of eicosapentaenoic acid or docosahexaenoic acid, in combination with other drugs, for treating cardiovascular disorders in patients suffering from urogenital disorders; preventing or treating underlying risk factors such as hypertension, dyslipidemia, obesity and diabetes |
| 05/29/2008 | US20080125488 Lactate Containing Pharmaceutical Composition and Uses Thereof |
| 05/29/2008 | US20080125481 Isoflavone metabolites |
| 05/29/2008 | US20080125472 Use of an inhibitor of the renin-angiotensin system; candesartan, candesartan cilexetil, losartan, valsartan, irbesartan, tasosartan, telmisartan, and eprosartan |
| 05/29/2008 | US20080125455 disorders of the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus; sleep apnea; (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine and (S)-1-[1-(1,2,3,6,7,8-hexahydrocyclopent[g]indolyl)]-2-propylamine |
| 05/29/2008 | US20080125446 For example, 6-amino-2-(chloro or fluoro)-8-(arylthio(oxo))-9H-purines; complex with Heat Shock Protein 90 (HSP 90); proliferative disorders such as breast cancer |
| 05/29/2008 | US20080125442 Cathepsin K Inhibitors and Atherosclerosis |